drugset / Trial / NCT01403389
A Study of the Activity of Eculizumab for Prevention of Delayed Graft Function In Deceased Donor Kidney Transplant
RandomizedParallel-groupTriple-blindPrevention
Summary
The purpose of this study is to determine if Eculizumab is safe and effective in the prevention of delayed graft function following deceased donor kidney transplantation.
Timeline
- Start
- 2011-12-01
- Primary completion
- 2013-08-06
- Completion
- 2014-02-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Eculizumab | Monoclonal antibody | 1200 mg | Intravenous |